SEC ownership of CUMBERLAND PHARMACEUTICALS INC

Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001087294.

Comparable stake leader

A. J. Kazimi

Disclosed value leader

A. J. Kazimi

Comparable rows

39/48

Latest evidence

30 Jun 2026

Top shareholders Insider holders Latest transactions
Public ticker
CPIX on Nasdaq
Parsed ownership sources
3/4/5, 13D/G, and 13F
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
Largest SEC-reported holder
A. J. Kazimi
Ranking: Comparable ownership first, then disclosed value
Ownership snapshot CIK-linked ownership evidence from parsed SEC filings. 3 signals
Comparable ownership rows
39 of 48
Meaning: Rows with safely comparable ownership %
Latest 13D/G holder
A. J. Kazimi
Source: Latest parsed Schedule 13D/G stake
Latest parsed ownership date
30 Jun 2026
Freshness: Most recent filing date in this holder set
Issuer Names, identifiers, and filing context for this profile. 2 identity fields
Issuer CIK
0001087294
Issuer location
Nashville,, TN

Ownership snapshot

Top shareholders of CUMBERLAND PHARMACEUTICALS INC (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
A. J. Kazimi
Disclosed value leader
A. J. Kazimi
Comparable rows
39/48
Latest evidence
30 Jun 2026
3/4/5 13D/G 13F Lead comparable stake: 38% 9 rows are not safely comparable across share classes. 13D/G row: A. J. Kazimi Showing 1-8 of 48 holder rows.

Quick read

A. J. Kazimi leads the comparable SEC ownership view at 38%.

39 of 48 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens A. J. Kazimi's linked filing trail.
Comparable ownership Top 5
A. J. Kazimi 38%
Ikarian Capital, LLC 4.9%
INTEGRATED CORE STRATEGIES (US) LLC 4%
Kenneth Krogulski 2%
Joseph C. Galante 0.42%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-8 of 48 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
A. J. Kazimi
3/4/5 13D/G
Chairman and CEO, Director, 10%+ Owner
3/4/5 13D/G
38%
from 13D/G
$27,934,548
6,263,310 shares
mixed-class rows
 — 18 Mar 2026
Ikarian Capital, LLC
13D/G 13F
Company
13D/G 13F
4.9%
$3,545,020
730,932 shares
 $0 31 Mar 2025
INTEGRATED CORE STRATEGIES (US) LLC
13D/G
13D/G
4%
$1,618,467
598,634 shares
 -$571,171 30 Sep 2025
Kenneth Krogulski
3/4/5
Director
3/4/5
2%
$1,354,474
302,338 shares
 — 18 Mar 2026
Joseph C. Galante
3/4/5
Director
3/4/5
0.42%
$285,178
63,656 shares
 — 18 Mar 2026
James Jones
3/4/5
Director
3/4/5
0.31%
$209,946
46,863 shares
 — 18 Mar 2026
Caroline Young
3/4/5
Director
3/4/5
0.23%
$157,288
35,109 shares
 — 18 Mar 2026
Martin S. Brown Jr.
3/4/5
Director
3/4/5
0.07%
$46,144
10,300 shares
 — 18 Mar 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Forms 3/4/5 flow

Insider trading overview

Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 13 Sep 2025.

Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value Sell value
Shares: 0 Shares: 0
Window (months) Buy shares Sell shares Buy value Sell value Net value
0-3 0 0 $0 $0 $0
3-6 0 0 $0 $0 $0
6-9 0 0 $0 $0 $0
9-12 0 0 $0 $0 $0

Reporting owners

Insider holders from Forms 3/4/5

Showing 1-15 of 15 reporting-owner rows connected to CUMBERLAND PHARMACEUTICALS INC. Open a relationship link for the CIK-to-CIK filing trail.

Rows
15
Largest Forms 3/4/5 holder
A. J. Kazimi
Net 12M change
$0
Latest report
18 Mar 2026
Name Relationship Holdings Value Past Year Net Change Change % Valuation Report Date
A. J. Kazimi Chairman and CEO, Director, 10%+ Owner $27,934,548 Mixed 18 Mar 2026
Kenneth Krogulski Director $1,354,474 Mixed 18 Mar 2026
Joseph C. Galante Director $285,178 Mixed 18 Mar 2026
Martin E. Cearnal Sr VP/Chief Commercial Officer, Director $277,904 Mixed 17 Mar 2022
Leo Pavliv SVP and Chief Development Off. $220,351 Mixed 31 May 2022
James Jones Director $209,946 Mixed 18 Mar 2026
Joey A. Jacobs Director $167,306 Mixed 14 Jan 2023
Caroline Young Director $157,288 Mixed 18 Mar 2026
James L. Herman VP and Chief Compliance Office $95,645 Mixed 18 Mar 2026
Todd M. Anthony Vice Pres Organizational Dev $93,060 Mixed 18 Mar 2026
Bitterman Chris T. Vice Pres Sales & Marketing $82,720 Mixed 18 Mar 2026
John M. Hamm VP Chief Financial Officer $78,843 Mixed 18 Mar 2026
Martin S. Brown Jr. Director $46,144 Mixed 18 Mar 2026
Jonathan Griggs Director $25,165 Mixed 17 Mar 2021
Michael Bonner Chief Financial Officer $19,924 Mixed 17 Mar 2021

Recent insider transactions for CUMBERLAND PHARMACEUTICALS INC

Showing up to 300 recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % SEC-reported value SEC-reported price Shares Shares owned Date Ownership
Martin S. Brown Jr. CPIX Common Stock Award 21.2% 1,800 10,300 18 Mar 2026 Direct
Joseph C. Galante CPIX Common Stock Award 2.91% 1,800 63,656 18 Mar 2026 Direct
James Jones CPIX Common Stock Award 3.99% 1,800 46,863 18 Mar 2026 Direct
Kenneth Krogulski CPIX Common Stock Award 1.96% 5,800 302,338 18 Mar 2026 Direct
Caroline Young CPIX Common Stock Award 5.4% 1,800 35,109 18 Mar 2026 Direct
Todd M. Anthony CPIX Options (right to buy) Award 16.7% 3,000 21,000 18 Mar 2026 Direct
Bitterman Chris T. CPIX Options (right to buy) Award 18.8% 3,000 19,000 18 Mar 2026 Direct
John M. Hamm CPIX Options (right to buy) Award 19.7% 3,000 18,250 18 Mar 2026 Direct
James L. Herman CPIX Options (right to buy) Award 13.5% 2,500 21,000 18 Mar 2026 Direct
A. J. Kazimi CPIX Options (right to buy) Award 21.4% 100,000 568,000 18 Mar 2026 Direct
A. J. Kazimi CPIX Common Stock Tax liability -0.1% -5,845 5,695,310 16 Mar 2026 Direct
Caroline Young CPIX Common Stock Small acquisition under Rule 16a-6 0.02% 5 33,309 31 Dec 2025 Direct
James Jones CPIX Common Stock Small acquisition under Rule 16a-6 0.02% 7 45,063 31 Dec 2025 Direct
A. J. Kazimi CPIX Common Stock Small acquisition under Rule 16a-6 7 5,701,155 31 Dec 2025 Direct
Kenneth Krogulski CPIX Common Stock Small acquisition under Rule 16a-6 0.02% 62 296,538 31 Dec 2025 Direct
Caroline Young CPIX Common Stock Small acquisition under Rule 16a-6 0.01% 2 33,304 30 Dec 2025 Direct
James Jones CPIX Common Stock Small acquisition under Rule 16a-6 0.02% 8 45,056 30 Dec 2025 Direct
A. J. Kazimi CPIX Common Stock Small acquisition under Rule 16a-6 8 5,701,148 30 Dec 2025 Direct
Kenneth Krogulski CPIX Common Stock Small acquisition under Rule 16a-6 0.02% 54 296,476 30 Dec 2025 Direct
Caroline Young CPIX Common Stock Small acquisition under Rule 16a-6 0.01% 2 33,302 29 Dec 2025 Direct
James Jones CPIX Common Stock Small acquisition under Rule 16a-6 0.02% 8 45,048 29 Dec 2025 Direct
A. J. Kazimi CPIX Common Stock Small acquisition under Rule 16a-6 8 5,701,140 29 Dec 2025 Direct
Kenneth Krogulski CPIX Common Stock Small acquisition under Rule 16a-6 0.02% 54 296,422 29 Dec 2025 Direct
Caroline Young CPIX Common Stock Small acquisition under Rule 16a-6 0.01% 2 33,300 26 Dec 2025 Direct
James Jones CPIX Common Stock Small acquisition under Rule 16a-6 0.02% 8 45,040 26 Dec 2025 Direct
A. J. Kazimi CPIX Common Stock Small acquisition under Rule 16a-6 8 5,701,132 26 Dec 2025 Direct
Kenneth Krogulski CPIX Common Stock Small acquisition under Rule 16a-6 0.02% 54 296,368 26 Dec 2025 Direct
Caroline Young CPIX Common Stock Small acquisition under Rule 16a-6 0.01% 2 33,298 24 Dec 2025 Direct
James Jones CPIX Common Stock Small acquisition under Rule 16a-6 0.02% 8 45,032 24 Dec 2025 Direct
A. J. Kazimi CPIX Common Stock Small acquisition under Rule 16a-6 8 5,701,124 24 Dec 2025 Direct
Kenneth Krogulski CPIX Common Stock Small acquisition under Rule 16a-6 0.02% 54 296,314 24 Dec 2025 Direct
Caroline Young CPIX Common Stock Small acquisition under Rule 16a-6 0.01% 2 33,296 23 Dec 2025 Direct
James Jones CPIX Common Stock Small acquisition under Rule 16a-6 0.02% 8 45,024 23 Dec 2025 Direct
A. J. Kazimi CPIX Common Stock Small acquisition under Rule 16a-6 8 5,701,116 23 Dec 2025 Direct
Kenneth Krogulski CPIX Common Stock Small acquisition under Rule 16a-6 0.02% 54 296,260 23 Dec 2025 Direct
Caroline Young CPIX Common Stock Small acquisition under Rule 16a-6 0.01% 2 33,294 22 Dec 2025 Direct
James Jones CPIX Common Stock Small acquisition under Rule 16a-6 0.02% 7 45,016 22 Dec 2025 Direct
A. J. Kazimi CPIX Common Stock Small acquisition under Rule 16a-6 7 5,701,108 22 Dec 2025 Direct
Kenneth Krogulski CPIX Common Stock Small acquisition under Rule 16a-6 0.02% 50 296,206 22 Dec 2025 Direct
Caroline Young CPIX Common Stock Small acquisition under Rule 16a-6 0.01% 2 33,292 19 Dec 2025 Direct
James Jones CPIX Common Stock Small acquisition under Rule 16a-6 0.02% 8 45,009 19 Dec 2025 Direct
A. J. Kazimi CPIX Common Stock Small acquisition under Rule 16a-6 8 5,701,101 19 Dec 2025 Direct
Kenneth Krogulski CPIX Common Stock Small acquisition under Rule 16a-6 0.02% 52 296,156 19 Dec 2025 Direct
Caroline Young CPIX Common Stock Small acquisition under Rule 16a-6 0.01% 3 33,290 18 Dec 2025 Direct
James Jones CPIX Common Stock Small acquisition under Rule 16a-6 0.02% 10 45,001 18 Dec 2025 Direct
A. J. Kazimi CPIX Common Stock Small acquisition under Rule 16a-6 10 5,701,093 18 Dec 2025 Direct
Kenneth Krogulski CPIX Common Stock Small acquisition under Rule 16a-6 0.02% 67 296,104 18 Dec 2025 Direct
Caroline Young CPIX Common Stock Small acquisition under Rule 16a-6 0.01% 3 33,287 17 Dec 2025 Direct
James Jones CPIX Common Stock Small acquisition under Rule 16a-6 0.02% 10 44,991 17 Dec 2025 Direct
A. J. Kazimi CPIX Common Stock Small acquisition under Rule 16a-6 10 5,701,083 17 Dec 2025 Direct
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .